Ioannis Koumoutsos

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres

Mark Samaan, Polychronis Pavlidis, Emma Johnston et al. · Frontline Gastroenterology · 2016 · 51 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms

Bridgette Wilson, Özge Eyice, Ioannis Koumoutsos et al. · Nutrients · 2021 · 49 citations · Full text

Life Sciences, Immunology, Nutritional Sciences +17

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

Shaji Sebastian, G Walker, Nicholas A. Kennedy et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 38 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study

Mark Samaan, Katrina Forsyth, Jonathan Segal et al. · Journal of Crohn s and Colitis · 2018 · 36 citations · Full text

Medicine, Clinical Sciences, Surgery +9